Literature DB >> 17310216

High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus.

Chenggong Yu1, Xiaoqi Zhang, Qin Huang, Michael Klein, Raj K Goyal.   

Abstract

This study describes the high-fidelity DNA histograms in different stages of neoplastic progression to Barrett's adenocarcinoma (BAC). High-fidelity DNA histograms were obtained with image cytometry on sections, and were classified based on DNA index values of the peaks into diploid, mild aneuploid, moderate aneuploid and severe aneuploid. Heterogeneity index (HI) representing cells with different DNA content and the 5N exceeding cell fraction were determined. One hundred and eighty-seven cases, including 34 normal gastrointestinal mucosa (control), 66 Barrett's-specialized intestinal metaplasia (SIM), 22 low-grade dysplasia (LGD), 22 high-grade dysplasia (HGD) and 43 BAC were investigated. Controls showed sharp diploid peaks with HI values less than 13, and no 5N exceeding nuclei. SIM showed a spectrum of histograms including diploid, mild aneuploid and moderate aneuploid histograms. The frequency and severity of aneuploidy increased with worsening histological grades of dysplasia. All BAC cases were aneuploid, with moderate or severe aneuploidy. Marked elevated HI values (>20) and 5N exceeding fractions (>5%) were found in 5%, 32%, 50% and 88% of cases with SIM, LGD, HGD and BAC, respectively. The high-fidelity DNA histograms suggest that (1) Barrett's SIM may already be dysplastic in nature, and all BAC may be markedly aneuploid; and (2) elevated cellular DNA heterogeneity and 5N fractions may be markers of progressive chromosomal changes and 'unstable aneuploidy' that identifies progressive lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17310216     DOI: 10.1038/labinvest.3700531

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  14 in total

Review 1.  [Barrett's esophagus. An update].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

2.  Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium.

Authors:  Weitian Liu; Hejin Hahn; Robert D Odze; Raj K Goyal
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

3.  Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth.

Authors:  Jagannath Pal; Mariateresa Fulciniti; Puru Nanjappa; Leutz Buon; Yu-Tzu Tai; Pierfrancesco Tassone; Nikhil C Munshi; Masood A Shammas
Journal:  Cancer Genomics Proteomics       Date:  2012 Mar-Apr       Impact factor: 4.069

Review 4.  The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus.

Authors:  David E Fleischer; Robert Odze; Bergein F Overholt; John Carroll; Kenneth J Chang; Ananya Das; John Goldblum; Daniel Miller; Charles J Lightdale; Jeffrey Peters; Richard Rothstein; Virender K Sharma; Daniel Smith; Victor Velanovich; Herbert Wolfsen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2010-04-20       Impact factor: 3.199

5.  Quantitation of spatial and temporal variability of biomarkers for Barrett's Esophagus.

Authors:  J Nwachokor; O Tawfik; M Danley; S Mathur; J House; P Sharma; L K Christenson; A Bansal
Journal:  Dis Esophagus       Date:  2017-09-01       Impact factor: 3.429

Review 6.  Predictors of progression in Barrett's esophagus: current knowledge and future directions.

Authors:  Ganapathy A Prasad; Ajay Bansal; Prateek Sharma; Kenneth K Wang
Journal:  Am J Gastroenterol       Date:  2010-01-26       Impact factor: 10.864

Review 7.  Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.

Authors:  Chin-Ann J Ong; Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

8.  Whole slide image cytometry: a novel method to detect abnormal DNA content in Barrett's esophagus.

Authors:  Yinhai Wang; Damian T McManus; Kenneth Arthur; Brian T Johnston; Andrew J Kennedy; Helen G Coleman; Liam J Murray; Peter W Hamilton
Journal:  Lab Invest       Date:  2015-08-03       Impact factor: 5.662

9.  Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma.

Authors:  Subodh Kumar; Leutz Buon; Srikanth Talluri; Marco Roncador; Chengcheng Liao; Jiangning Zhao; Jialan Shi; Chandraditya Chakraborty; Gabriel Gonzalez; Yu-Tzu Tai; Rao Prabhala; Mehmet K Samur; Nikhil C Munshi; Masood A Shammas
Journal:  Commun Biol       Date:  2021-05-24

10.  GERD-Barrett-Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers?

Authors:  Romana Illig; Eckhard Klieser; Tobias Kiesslich; Daniel Neureiter
Journal:  Gastroenterol Res Pract       Date:  2013-03-20       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.